Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 29, 2023 12:54 PM 3 min read

Will Beyonce Concert Film Give AMC Another #1 Hit? Could Shareholders Be Crazy In Love With Q4 Earnings?

by Chris Katje Benzinga Staff Writer
Follow

Legendary musician Beyonce had one of the highest-grossing tours of 2023 with her "Renaissance Tour." A concert film from AMC Entertainment Holdings (NYSE:AMC) highlights the success of the tour and demand for the singer.

What Happened: Movie theater company AMC could have two of the biggest concert tour films of all time with the releases of the Taylor Swift "The Eras Tour" film and the upcoming "Renaissance: A Film by Beyonce."

Hitting theaters on Nov. 30, the new Beyonce concert tour film is expected to be the top-grossing movie this week. Estimates from Deadline call for the movie to gross around $20 million domestically and around $20 million in international markets, which could give the movie a $40 million worldwide opening.

For comparison, the Taylor Swift concert film had an opening of $92.8 million. Presales for the Beyonce film are estimated around $6 million compared to $65 million for Swift's film.

While Beyonce's film could come in significantly lower than the Swift film, a $20 million open would put the movie on par with past concert films from Justin Bieber and Michael Jackson.

The film comes with a higher ticket price of around $22 and will also be shown in premium theater formats such as screens at IMAX Corp (NYSE:IMAX) theater locations.

Like the Swift concert tour film, the Beyonce film will be shown in theaters from Thursday through Sunday each week, excluding several weekdays. This could drive additional weekend demand for the film.

Other movie theater chains like Cinemark Holdings (NYSE:CNK) will also show the film.

Related Link: AMC Q3 Earnings Highlights: Revenue Beat, EPS Beat; Q4 To Include Taylor Swift, Beyonce Film Results; Hollywood Strike’s Impact To Be Felt In 2024

Why It's Important: The Swift concert tour film, which was distributed by AMC, grossed around $250 million worldwide and has a couple of weeks left before it heads to at-home viewing soon on the singer's Dec. 13 birthday.

The timing of the releases of the Swift concert film and the upcoming Beyonce concert film could be important for shareholders of AMC.

Both films were released in the company's fourth quarter and will be part of that quarterly earnings report, likely to come in February.

AMC Price Action: AMC shares are up 5.22% to $7.05 on Wednesday. Shares of the movie theater company are down 80% year-to-date in 2023.

Read Next: Beyonce Has The Second Biggest Album Debut Of 2022: Here's A Stock To Watch

Photos: RENAISSANCE: A FILM BY BEYONCÉ 12.01, (c) Parkwood Entertainment; Beyoncé at film premiere, Sat. Nov. 25, photo: Mason Poole. Both images via Beyoncé press site via Cison

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EntertainmentTop StoriesTrading IdeasBeyoncemovie stocksmovie theater stocksmoviesTaylor Swift
AMC Logo
AMCAMC Entertainment Holdings Inc
$1.241.64%
Overview
CNK Logo
CNKCinemark Holdings Inc
$26.36-0.19%
IMAX Logo
IMAXImax Corp
$37.68-%

The fourth quarter financial results from AMC could prove important given the timing of the two distributed concert films and the holiday slate of movies. The movie theater company could share additional details on the impact of the Hollywood Strike, which has led to several blockbuster movies being shifted from 2024 to 2025.

AMC Logo
AMCAMC Entertainment Holdings Inc
$1.241.64%
Overview
CNK Logo
CNKCinemark Holdings Inc
$26.36-0.19%
IMAX Logo
IMAXImax Corp
$37.68-%
Comments
Loading...